Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
We evaluated: (1) punitive prenatal substance use policies (PSUPs) criminalizing prenatal substance use or defining it as child maltreatment; (2) supportive PSUPs granting pregnant females priority
The aim of this study is to explore caregivers’ experiences accessing opioid use treatments with young people and their needs and ideas for improving such treatments.
Given the recent increase in child maltreatment reports related to parental substance use, research should explore the correlation between buprenorphine treatment and child maltreatment–related out
To identify key gaps in overdose prevention interventions for mothers who use drugs and the paradoxical impact of institutional practices that can increase overdose risk in the context of punitive
A need exists to enhance our understanding of modifiable factors, facilitators, and barriers to MOUD utilization and adherence in the perinatal period to improve maternal and child outcomes.
We aimed to evaluate the association between benzodiazepine use in the first trimester of pregnancy and the risk of major congenital malformations.
Understanding substance use treatment experiences is important to improve access, and retention, and no review or synthesis of research addressing the treatment experiences of pregnant women exists
We linked statewide PDMP and birth certificate data in Tennessee (TN) to determine patterns of prescription opioid and benzodiazepine use during pregnancy.
Opioid use disorder (OUD) in pregnancy disproportionately impacts rural and American Indian (AI) communities.
We sought to further quantify the risk of anomalies after opioid analgesic exposure during the first trimester in a population-based cohort study.